Answer
Bosentan blocks both endothelin A (ETA) and endothelin B (ETB) receptors, with slightly higher affinity for ETA receptors, and does not bind to other receptors.
Sources for this answer
- Bosentan Milpharm 125 mg film-coated tabletsAurobindo Pharma - Milpharm Ltd. · emc · SmPC §5.1 Pharmacodynamic properties · Version 11Document updated
Sources checked